In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.
第一作者:
A R,Hasugian
第一单位:
National Institute of Health Research and Development, Ministry of Health, Jakarta, Indonesia. rnp@menzies.edu.au
作者:
医学主题词
青少年(Adolescent);年龄分布(Age Distribution);阿莫地喹(Amodiaquine);动物(Animals);抗疟药(Antimalarials);氯喹(Chloroquine);置信区间(Confidence Intervals);抗药性(Drug Resistance);药物耐受性(Drug Tolerance);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);半数抑制浓度(Inhibitory Concentration 50);男(雄)性(Male);门诊病人(Outpatients);寄生虫血症(Parasitemia);间日疟原虫(Plasmodium vivax);前瞻性研究(Prospective Studies);复发(Recurrence);农村卫生(Rural Health);时间因素(Time Factors);治疗失败(Treatment Failure);治疗结果(Treatment Outcome)
DOI
10.1128/AAC.01511-08
PMID
19104023
发布时间
2021-10-20
- 浏览30
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



